Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #160505 on Biotech Values
lax20m
04/30/13 9:43 AM
#160506 RE: DewDiligence #160505
biomaven0
04/30/13 10:50 AM
#160509 RE: DewDiligence #160505
Canceling a 10b5-1 plan is permitted at any time because not trading is not considered a form of insider trading.
On March 25, 2009, the SEC staff revised its interpretative guidance regarding the circumstances under which the affirmative defense in Rule 10b5-1(c) is available. In particular, the staff followed the approach previously urged by some commentators to clarify (1) that the cancellation of a 10b5-1 plan could call the good faith of other, executed plans into doubt and (2) that the Supreme Court's decision in Blue Chip Stamps v. Manor Drug Stores, 421 U.S. 723 (1975), did not affect the SEC's ability to bring an enforcement action against a would-be insider trader who canceled a trading plan and did not trade in a particular transaction because a subsequent decision, Merrill Lynch, Pierce, Fenner & Smith, Inc., v. Dabit, 547 U.S. 71 (2006), made clear that Blue Chip Stamps dealt only with the implied private right of action for violations of Rule 10b-5 and not the "in connection with" requirement for all Rule 10b-5 violations.
ilpapa
04/30/13 11:41 AM
#160511 RE: DewDiligence #160505